Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one
CHAQ.U
CHAQ.U was delisted on the 2nd of September, 2021.
11 hedge funds and large institutions have $29.4M invested in Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one in 2020 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 4 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
7% less capital invested
Capital invested by funds: $31.6M → $29.4M (-$2.23M)
27% less funds holding
Funds holding: 15 → 11 (-4)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFM
Boothbay Fund Management
New York
|
+$5.02M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$105 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SRCM
Sage Rock Capital Management
New York
|
-$3.87M |
| 2 |
LGM
Logos Global Management
San Francisco,
California
|
-$2.11M |
| 3 |
GCL
Glazer Capital LLC
New York
|
-$1.1M |
| 4 |
HF
HRT Financial
New York
|
-$5.23K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BFM
1
Boothbay Fund Management
New York
| $5.18M | +$5.02M | +479,815 | +1,744% |
|
|
IC
2
Ikarian Capital
Dallas,
Texas
| $4.24M | – | – | – |
|
|
SCM
3
Sio Capital Management
New York
| $4.24M | – | – | – |
|
|
RI
4
RTW Investments
New York
| $3.71M | – | – | – |
|
|
5
Citadel Advisors
Miami,
Florida
| $3.21M | +$105 | +10 | +0% |
|
|
KPF
6
K2 Principal Fund
Toronto,
Ontario, Canada
| $3.02M | – | – | – |
|
|
PC
7
Periscope Capital
Toronto,
Ontario, Canada
| $2.69M | – | – | – |
|
|
PVI
8
Pura Vida Investments
New York
| $1.63M | – | – | – |
|
|
HF
9
HRT Financial
New York
| $970K | -$5.23K | -500 | -0.5% |
|
|
HIM
10
HGC Investment Management
Toronto,
Ontario, Canada
| $530K | – | – | – |
|
11
Walleye Capital
New York
| $371 | – | – | – |
|
|
SRCM
12
Sage Rock Capital Management
New York
| – | -$3.87M | -367,100 | Closed |
|
|
LGM
13
Logos Global Management
San Francisco,
California
| – | -$2.11M | -200,000 | Closed |
|
|
GCL
14
Glazer Capital LLC
New York
| – | -$1.1M | -107,119 | Closed |
|
|
TRCT
15
Tower Research Capital (TRC)
New York
| – | -$2K | -200 | Closed |
|
CHAQ.U Hedge Fund Activity: Q4 2020 in Review
11 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one (CHAQ.U) for Q4 2020, worth a combined $29.4M — down 7% from $31.6M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of CHAQ.U and 0 opened new positions — a net loss of 4 holders — while 1 trimmed existing stakes and 2 added.
The largest buyer was Boothbay Fund Management, adding an estimated $5.02M. The largest seller was Sage Rock Capital Management, exiting entirely with an estimated $3.87M sold.
- 11 institutional investors held Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one (CHAQ.U) as of Q4 2020, down from 15 in Q3 2020.
- Funds reported $29.4M of Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one stock for Q4 2020, down 7% quarter-over-quarter.
- 0 funds opened new Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one positions in Q4 2020 and 4 closed out, a net change of -4 holders.
- The largest Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one buyer in Q4 2020 was Boothbay Fund Management, an estimated $5.02M added.
- The largest Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one seller in Q4 2020 was Sage Rock Capital Management, an estimated $3.87M sold.
Based on aggregated 13F filings for Q4 2020.